Scarica l'app Stockscreener
109.24
0.19%
0.21
Dopo l'orario di chiusura:
109.24
Precedente Chiudi:
$109.03
Aprire:
$108.88
Volume 24 ore:
547.50K
Relative Volume:
0.68
Capitalizzazione di mercato:
$2.77B
Reddito:
$302.00K
Utile/perdita netta:
$-117.10M
Rapporto P/E:
-9.8149
EPS:
-11.13
Flusso di cassa netto:
$-129.13M
1 W Prestazione:
+17.31%
1M Prestazione:
+14.08%
6M Prestazione:
+423.05%
1 anno Prestazione:
+740.31%
Intervallo 1D:
$106.70
$113.00
Intervallo di 1 settimana:
$94.50
$113.00
Portata 52W:
$12.66
$121.21
Cidara Therapeutics Inc Stock (CDTX) Company Profile
Nome
Cidara Therapeutics Inc
Settore
Industria
Telefono
858-752-6170
Indirizzo
6310 NANCY RIDGE DRIVE, SAN DIEGO, CA
Confronta CDTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CDTX
Cidara Therapeutics Inc
|
109.24 | 2.76B | 302.00K | -117.10M | -129.13M | -11.13 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Cidara Therapeutics Inc Stock (CDTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-16 | Iniziato | Morgan Stanley | Overweight |
| 2025-10-10 | Iniziato | JP Morgan | Overweight |
| 2025-06-18 | Ripresa | H.C. Wainwright | Buy |
| 2025-03-12 | Iniziato | Citizens JMP | Mkt Outperform |
| 2025-01-27 | Ripresa | Cantor Fitzgerald | Overweight |
| 2024-12-13 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-11-08 | Iniziato | Guggenheim | Buy |
| 2024-08-14 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2021-12-03 | Ripresa | H.C. Wainwright | Buy |
| 2021-09-22 | Aggiornamento | WBB Securities | Buy → Strong Buy |
| 2021-03-04 | Iniziato | Aegis Capital | Buy |
| 2019-09-04 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2018-07-26 | Iniziato | Citigroup | Buy |
| 2017-04-21 | Iniziato | Raymond James | Strong Buy |
| 2017-04-17 | Reiterato | H.C. Wainwright | Buy |
| 2017-04-12 | Iniziato | Ladenburg Thalmann | Buy |
| 2017-04-11 | Ripresa | Wedbush | Outperform |
| 2017-02-22 | Reiterato | H.C. Wainwright | Buy |
| 2017-02-22 | Aggiornamento | WBB Securities | Sell → Hold |
| 2016-12-21 | Ripresa | Leerink Partners | Outperform |
| 2016-12-19 | Iniziato | H.C. Wainwright | Buy |
| 2016-09-23 | Downgrade | WBB Securities | Hold → Sell |
| 2015-10-09 | Aggiornamento | WBB Securities | Sell → Hold |
| 2015-05-11 | Iniziato | Jefferies | Buy |
| 2015-05-11 | Iniziato | Leerink Partners | Outperform |
| 2015-05-11 | Iniziato | Needham | Buy |
| 2015-05-11 | Iniziato | Wedbush | Outperform |
| 2015-04-23 | Iniziato | WBB Securities | Sell |
Mostra tutto
Cidara Therapeutics Inc Borsa (CDTX) Ultime notizie
Does Cidara Therapeutics Inc. stock trade at a discount to peersJuly 2025 Market Mood & Real-Time Volume Trigger Notifications - newser.com
AlphaQuest LLC Makes New Investment in Cidara Therapeutics, Inc. $CDTX - MarketBeat
Jennison Associates LLC Invests $2.40 Million in Cidara Therapeutics, Inc. $CDTX - MarketBeat
Should you hold or exit Cidara Therapeutics Inc. nowMarket Rally & Fast Exit Strategy with Risk Control - newser.com
Signal strength of Cidara Therapeutics Inc. stock in tech scannersJuly 2025 Selloffs & Consistent Income Trade Ideas - newser.com
How Cidara Therapeutics Inc. stock benefits from strong dollarNew Guidance & Free Technical Pattern Based Buy Signals - newser.com
What to do if you’re stuck in Cidara Therapeutics Inc.July 2025 Momentum & AI Powered Market Trend Analysis - newser.com
Cidara Therapeutics (CDTX) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
What hedge fund moves indicate for Cidara Therapeutics Inc. (20D0) stockEarnings Summary Report & Daily Stock Momentum Reports - newser.com
Published on: 2025-10-31 05:10:02 - newser.com
How Cidara Therapeutics Inc. stock compares to growth peersWeekly Stock Summary & Free Weekly Chart Analysis and Trade Guides - newser.com
Will Cidara Therapeutics Inc. stock outperform international peers2025 Big Picture & Safe Entry Momentum Tips - newser.com
Why Cidara Therapeutics Inc. stock is in analyst buy zone2025 Bull vs Bear & Consistent Income Trade Recommendations - newser.com
Will Cidara Therapeutics Inc. stock deliver long term returns2025 Pullback Review & Reliable Price Breakout Alerts - newser.com
How to escape a deep drawdown in Cidara Therapeutics Inc.2025 Historical Comparison & Stock Portfolio Risk Management - newser.com
Is Cidara Therapeutics Inc. forming a bottoming base2025 Risk Factors & Safe Capital Growth Trade Ideas - newser.com
Using Ichimoku Cloud for Cidara Therapeutics Inc. technicalsJuly 2025 Short Interest & AI Powered Buy/Sell Recommendations - newser.com
Cidara Therapeutics (CDTX) Price Target Increased by 24.94% to 167.79 - Nasdaq
How risky is Cidara Therapeutics Inc. stock now2025 Volatility Report & Low Drawdown Momentum Trade Ideas - newser.com
Cidara Therapeutics (NASDAQ:CDTX) Trading 8.2% HigherHere's What Happened - MarketBeat
Cidara Therapeutics to Participate in November Investor Conferences - The Manila Times
Cidara Therapeutics Inc Azioni (CDTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.62%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):